2X Match My Gift
In honor of World Cancer Research Day, your donation will be DOUBLED to accelerate lifesaving colorectal cancer research.


Every year, thousands of passionate supporters step forward — some in memory, some in hope, and many in solidarity — to take part in the Colorectal Cancer Alliance’s Walk to End Colon Cancer.
This year’s event series was nothing short of extraordinary. Across nine cities nationwide, our community showed what’s possible when compassion, determination, and action meet on the pavement to #WalkLoud.
Our communities came together at the Walk to End Colon Cancer.
raised
participants
teams
The Walk was also assisted by the generous dedication of 217 volunteers across nine cities.
Every step taken and every dollar raised helped move the mission forward in ways that will be felt long after the finish line.
Across the nation, Tampa launched the season with nearly 1,000 participants and raised more than $64,000. Denver, Cleveland, Phoenix, and Philadelphia raised the bar on impact, welcoming more than 1,000 walkers and raising over $100,000 per city.
Adding to the impact of the Walk to End Colon Cancer, DC ScopeItOut — a walk around the National Mall occurring every March — raised more than $330,000 across 118 teams.
Walk participation sparks vital awareness, encouraging conversations, screenings, and early detection. At the same time, the Walk supports critical prevention programs and patient services — ensuring those facing colorectal cancer aren’t alone.
And those who #WalkLoud also fuel research that brings us closer to new treatments. In the last year alone, the Alliance's Project Cure CRC has invested in more than 30 new research projects innovating how we will end this disease.
“Whether you walked for yourself, a loved one, or simply because you care, your commitment powered extraordinary momentum this year,” said Michael Sapienza, CEO of the Colorectal Cancer Alliance. “Thank you for showing up, stepping forward, and helping bring us closer to a world free of colorectal cancer.”
Next year’s Walk to End Colon Cancer dates will be listed on the Alliance’s event calendar as they become available for registration.

The U.S. Food and Drug Administration has given researchers at the University of Colorado Anschutz Medical Campus permission to begin a clinical trial of CAR T-cell therapy for people with advanced colorectal cancer who have already tried the standard treatments without lasting success.

Andy said his lifestyle made it easier to ignore the blood in the stool, a symptom of colorectal cancer. But the “mirage of invincibility,” as he called it, was about to vanish.

Each of the four appointees to the Alliance's Board brings unique professional expertise and a personal commitment to the organization's mission to end colorectal cancer in our lifetime.